SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense volatility and community division after a rapid parabolic surge followed by a steep price collapse that erased the vast majority of its recent gains. While some participants are calling for a short squeeze or treating the drop as a discount buying opportunity, others are warning of a classic pump-and-dump scheme and highlighting official investigations into potential market manipulation.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to a major expansion in its partnership with NVIDIA to integrate QNX safety-certified software into industrial, medical, and robotics edge AI platforms. The community is buzzing with optimism, with many long-term shareholders viewing this as a pivotal validation of the company's turnaround and its transition into a key player for physical AI and autonomous systems.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is undergoing a massive, mechanical short squeeze driven by a highly concentrated ownership structure that has effectively locked the float and left short sellers with little room to exit. The community is actively debating the sustainability of this parabolic move, with many traders warning of an inevitable and sharp correction while others point to the lack of available shares to borrow as fuel for further upside.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as retail sentiment surges following the termination of a dilutive equity facility and regulatory approval to remove pattern day trading restrictions. The community is actively discussing a potential short squeeze, citing significant institutional interest and price momentum as the stock moves toward key breakout levels.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is trending as investors react to a government executive order aimed at expediting the review of psychedelic treatments, including ibogaine. The community is actively debating the company's ability to capitalize on this news, with bulls pointing to their GMP-compliant supply chain and potential pipeline, while bears remain skeptical about the firm's history of dilution and long-term financial viability.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is gaining momentum as investors pivot toward its "Physical AI" narrative, bolstered by a strong Q4 earnings surprise that featured record sensor shipments and the strategic acquisition of StereoLabs. The community is actively discussing Ouster's potential to dominate critical infrastructure sectors and defense applications as domestic supply chain preferences grow, though traders remain cautious about managing volatility around upcoming hardware product cycles.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is experiencing significant volatility and volume spikes following the release of positive phase 3 trial results for its treatment-resistant depression candidate, COMP360. Investors are actively debating the long-term commercialization strategy, potential acquisition interest, and the impact of a newly announced public offering on near-term share price performance.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased volatility and investor interest following a better-than-expected Medicare Advantage rate announcement from CMS, which has alleviated regulatory concerns. The community is actively debating whether this news marks a structural recovery and an opportunity for a breakout, or if the stock remains vulnerable to further downside and potential volatility ahead of upcoming earnings.

Alaska Air Group, Inc. is a holding company, which engages in the provision of air transportation services. It operates through the following segments: Alaska Airlines, Hawaiian Airlines, and Regional. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo. The Hawaiian Airlines segment refers to scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. The Regional segment consists of Horizon's and other third-party carriers’ scheduled air transportation on E175 aircraft for passengers under CPAs. The company was founded in 1985 and is headquartered in Seattle, WA.

Alaska Air Group Inc.

Alaska Air Group is trending as investors digest the airline's latest earnings report, which was heavily impacted by rising fuel costs and operational challenges. While the community is actively debating the company's long-term strategy and guidance suspension, many traders are closely monitoring these levels for potential buying opportunities.

BlackBerry is trending as investors rally around its growing QNX software backlog and strategic collaborations, including recent integrations with major automotive and defense partners. Community members are actively discussing the company's turnaround and potential for future valuation growth as it establishes its role as a fundamental provider for secure, safety-critical systems in automotive and physical AI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Joseph Oliveto Sells 36,500 Shares of Milestone Pharmaceuticals (NASDAQ:MIST) Stock

Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) CEO Joseph Oliveto sold 36,500 shares of the firm's stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $2.26, for a total value of $82,490.00. Following the completion of the sale, the chief...

Milestone Pharmaceuticals (NASDAQ:MIST) Upgraded to Strong-Buy at Raymond James Financial

Raymond James Financial raised Milestone Pharmaceuticals to a "strong-buy" rating in a research note on Thursday...

Milestone Pharmaceuticals (NASDAQ:MIST) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded shares of Milestone Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Saturday...

Raymond James Financial Initiates Coverage on Milestone Pharmaceuticals (NASDAQ:MIST)

Raymond James Financial began coverage on Milestone Pharmaceuticals in a report on Friday. They issued a "strong-buy" rating and a $6.00 price objective on the stock...

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Receives Consensus Recommendation of "Hold" from Brokerages

Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) has been assigned an average recommendation of "Hold" from the six ratings firms that are currently covering the company, Marketbeat.com...

Milestone Pharmaceuticals (NASDAQ:MIST) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen upgraded Milestone Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...

Milestone Pharmaceuticals (MIST) Projected to Post Earnings on Tuesday

Milestone Pharmaceuticals (NASDAQ:MIST) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 31. (View Earnings Report at...

Equities Analysts Issue Forecasts for MIST FY2028 Earnings

Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Free Report) - Equities researchers at HC Wainwright lowered their FY2028 earnings per share estimates for shares of Milestone Pharmaceuticals in a research report issued on Friday, March 20th. HC Wainwright analyst B. Folkes now forecasts that the compa...

Milestone Pharmaceuticals (NASDAQ:MIST) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Milestone Pharmaceuticals (NASDAQ:MIST - Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02. The firm had revenue of $1.44 million during the quarter, compared to the...

Milestone Pharmaceuticals Q4 Earnings Call Highlights

Milestone Pharmaceuticals (NASDAQ:MIST) executives highlighted the company's transition to commercialization during a year-end 2025 update call, following the U.S. Food and Drug Administration's...

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.

MIST
Milestone Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MIST News

MISTMilestone Pharmaceuticals Inc